BOSTON (AP) _ Yumanity Therapeutics, Inc. (YMTX) on Monday reported a loss of $3.4 million in its third quarter.

On a per-share basis, the Boston-based company said it had a loss of 31 cents.

The biopharmaceutical company posted revenue of $1.4 million in the period.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on YMTX at https://www.zacks.com/ap/YMTX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News